ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
90,000
-1,800 (-1.96%)
Sep 11, 2026, 3:30 PM KST

ST Pharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
76,79654,99234,71219,58118,0003,312
Depreciation & Amortization
33,79929,88125,58223,02717,60014,414
Loss (Gain) From Sale of Assets
302.38328.521,6920.62515.432,543
Asset Writedown & Restructuring Costs
-31-60.5-47.79---
Loss (Gain) From Sale of Investments
-6,281-6,870-12,3908,063628.83-147.24
Stock-Based Compensation
2,1421,5423,2465,2985,0192,116
Provision & Write-off of Bad Debts
1,6261,7153.87188.27-0.06-138.94
Other Operating Activities
17,33611,84319,9489,9206,0886,619
Change in Accounts Receivable
10,957-30,52953,012-25,749-47,568-6,471
Change in Inventory
-45,517-52,821-12,944-13,226-25,939-37,301
Change in Accounts Payable
2,3421,295-7,321-369.936,0718,169
Change in Other Net Operating Assets
19,1542,6743,958-25,43526,61514,154
Operating Cash Flow
112,62713,989109,4511,2987,0317,270
Operating Cash Flow Growth
59.47%-87.22%8329.82%-81.53%-3.29%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-35,332-47,072-82,806-43,244-60,479-51,792
Sale of Property, Plant & Equipment
48.2851.6168.5100.943.67612.72
Sale (Purchase) of Intangibles
-193.39-213.64-238.11-198.7108.52-125.09
Investment in Securities
-59,25417,089-8,021-40,70854,08542,492
Other Investing Activities
2,8283,8194,3541,662557.09779.23
Investing Cash Flow
-91,649-26,326-86,543-82,388-5,724-8,034

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-11,47925,00025,87820,000-
Long-Term Debt Issued
--190.16101,45416,500-
Total Debt Issued
10,65611,47925,190127,33236,500-
Short-Term Debt Repaid
----33,333--
Long-Term Debt Repaid
--20,900-25,890-1,861-16,750-1,019
Total Debt Repaid
-16,909-20,900-25,890-35,195-16,750-1,019
Net Debt Issued (Repaid)
-6,253-9,421-699.6892,13719,750-1,019
Issuance of Common Stock
8,021-----
Dividends Paid
-10,419-10,076-9,404-9,404-9,404-
Other Financing Activities
-953.86-585.48-849.82-1,331462.3903.14
Financing Cash Flow
-9,605-20,083-10,95481,40110,808-115.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
738.29-439.641,353-415.46-1,1171,457
Net Cash Flow
12,111-32,85913,308-103.9110,998578.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
77,295-33,08226,646-41,946-53,448-44,522
Free Cash Flow Growth
------
Free Cash Flow Margin
20.00%-9.97%9.73%-14.72%-21.44%-26.88%
Free Cash Flow Per Share
3545.25-1542.641366.16-2230.12-2841.64-2385.36
Levered Free Cash Flow
42,459-31,05710,548-58,932-68,609-73,918
Unlevered Free Cash Flow
44,982-28,53415,384-55,116-66,817-70,695

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
934.42578.08817.461,331929.58447.67
Cash Income Tax Paid
6,4718,7424,9552,1182,868-826.64
Change in Working Capital
-13,064-79,38136,705-64,780-40,821-21,449